research_focus	clinical_trial	gender	ethnicity	race	brief_title	brief_description	arm_name	biosample_type	arm_accession	max_age	study_accession	subject_accession	has_lab_test	species	condition_or_disease	has_assessment	assay_method	min_age
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192898	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	American Indian or Alaska Native	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192899	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Transcription profiling by array;Surface Plasmon Resonance;Cytometric Bead Array Assay;Sequencing	18.0
Vaccine Response	N	Male	Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192900	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Transcription profiling by array;Surface Plasmon Resonance;Cytometric Bead Array Assay;Sequencing	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192901	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192902	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192903	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192904	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192905	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192906	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192907	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192908	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192909	N	Homo sapiens	influenza	N	RNA sequencing;Cell Culture;Transcription profiling by array;Surface Plasmon Resonance	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192910	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192911	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192912	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192913	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192914	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Hispanic or Latino	Not Specified	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192915	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Asian	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192916	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;Feces;PBMC;Serum;Whole blood	ARM3826	40.0	SDY1086	SUB192917	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192918	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;Feces;PBMC;Serum;Whole blood	ARM3827	40.0	SDY1086	SUB192919	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;PBMC;Serum;Feces;Whole blood	ARM3827	40.0	SDY1086	SUB192920	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;Flow Cytometry;ELISA;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192921	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;PBMC;Serum;Feces;Whole blood	ARM3827	40.0	SDY1086	SUB192922	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;Flow Cytometry;ELISA;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	White	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;PBMC;Serum;Feces;Whole blood	ARM3827	40.0	SDY1086	SUB192923	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;Flow Cytometry;ELISA;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192924	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;PBMC;Serum;Feces;Whole blood	ARM3827	40.0	SDY1086	SUB192925	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;Flow Cytometry;ELISA;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192926	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192927	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Male	Hispanic or Latino	American Indian or Alaska Native	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192928	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Hispanic or Latino	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_A	Plasma;PBMC;Serum;Feces;Whole blood	ARM3826	40.0	SDY1086	SUB192929	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;ELISA;Flow Cytometry;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array	18.0
Vaccine Response	N	Female	Not Specified	Black or African American	Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Vax002_group_B	Plasma;PBMC;Serum;Feces;Whole blood	ARM3827	40.0	SDY1086	SUB192930	N	Homo sapiens	influenza	N	Mass Spectrometry;ELISPOT;RNA sequencing;Neutralizing Antibody Titer Assay;Flow Cytometry;ELISA;Cell Culture;Other;Surface Plasmon Resonance;Cytometric Bead Array Assay;Transcription profiling by array;Sequencing	18.0
Vaccine Response	N	Not Specified			Responses to Inactivated Influenza Vaccine (IIV) in adults with or without antibiotics	Single center, open mechanistic study in which subjects will be randomized to receive IIV per label at day 4 of a 5 day course of a specific antibiotic regimen (Group A) or IIV alone (Group B)	Mouse cohort	Protein	ARM4739	0.0	SDY1086	SUB194257	N	Mus musculus	influenza	N	Cytometric Bead Array Assay	0.0
